Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Michael E. Berens et al.|Cancer Discovery|2022Cited by 277
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A. Vitanza, Michael C. Jensen, Rebecca Ronsley et al.|Nature Medicine|2025Cited by 154
Locoregional infusion of EGFR806-CAR T cells for recurrent or refractory pediatric CNS tumors: Results of the completed BrainChild02 phase 1 clinical trialJuliane Gust, Julie R. Park, Bonnie Cole et al.|Neuro-Oncology|2025Cited by 16
IMMU-11. CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLSNicholas A. Vitanza, Julie Park, Ashley Wilson et al.|Neuro-Oncology|2021Cited by 8
IMMU-02. LOCOREGIONAL HER2CAR T CELLS FOR PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS: PRECLINICAL EFFICACY TO TOLERABILITY IN FIRST PATIENTNicholas A. Vitanza, Michael C. Jensen, Adam Johnson et al.|Neuro-Oncology|2019Cited by 2